(S)-Alpha,Alphal-Diphenyl-3-Pyrrolidineacetamide Tartrate

The (S)-enantiomer of α,α-diphenyl-3-pyrrolidineacetamide, isolated as its L-tartrate salt, crystallizes as a white to off‑white powder with a stoichiometric counterion ratio confirmed by alkalimetric titration against 0.1 N sodium hydroxide. This salt form is deliberately selected to impart a high lattice energy, yielding a melting point of **192–195 °C** (decomposition, by differential scanning calorimetry at **10 K/min** under nitrogen purge) versus the hygroscopic, low-melting free base. The product serves as a protected chiral synthon in the construction of muscarinic receptor antagonists and related nitrogen‑heterocycle libraries, where enantiomeric integrity and minimal moisture uptake during weighing are critical for reproducible asymmetric synthesis.

What Differentiates the Tartrate Salt from Free Base and Hydrochloride?

The free base of α,α-diphenyl-3-pyrrolidineacetamide is a viscous oil at ambient temperature, readily absorbing atmospheric carbon dioxide and water, which complicates accurate stoichiometric additions in air‑sensitive protocols. Conversion to the hydrochloride yields a crystalline solid, yet its aqueous solubility routinely exceeds **150 mg/mL**, making it prone to deliquescence in humid environments and creating processing challenges during filtration of hydrolysis‑sensitive reaction intermediates. The L‑tartrate salt, in contrast, exhibits a water solubility of approximately **28 mg/mL** at **25 °C**, low enough to permit straightforward vacuum filtration on Büchner funnels without caking, while still adequate for solution‑phase peptide coupling or reductive amination steps in polar aprotic solvent mixtures. A head‑to‑head comparison of physical stability was performed using dynamic vapor sorption (DVS) on a Surface Measurement Systems DVS Adventure instrument: at **60 % relative humidity**, the hydrochloride adsorbed **3.2 wt%** water within **120 minutes**, whereas the tartrate mass increase remained below **0.4 wt%** under identical conditions. This difference directly translates to less frequent oven drying of raw material drums prior to opening in a GMP kilo‑lab, reducing operator handling time and the risk of microbial contamination during sampling.

Physical Form and Handling in Dry and Humid Environments

The product is routinely milled and sieved through a **250 µm** mesh to provide a uniform particle size distribution for dry blending operations or direct charging into reaction vessels. Bulk density, determined according to USP<616> Method I, falls between **0.42 and 0.48 g/mL**. Residual solvent content is controlled by headspace gas chromatography per Ph. Eur. 2.4.24; lot‑release limits are set at ≤**0.1 %** for ethanol and ≤**0.05 %** for ethyl acetate, aligning with ICH Q3C Option 1 thresholds. Any batch exceeding these values is returned to a 40 °C vacuum oven and dried under −0.08 MPa until compliant. Because the tartrate moiety does not form a hydrate, no loss‑on‑drying excursion is observed below **105 °C**, a practical advantage over the mesylate salt, which retains lattice water up to **80 °C** and requires an extended isothermal hold during thermogravimetric analysis (TGA) to distinguish bound water from solvent. Shipment and storage recommendations are based on forced‑degradation studies. Sealed double‑bagged foil laminates are used; a silica gel desiccant pouch placed between primary and secondary layers maintains headspace relative humidity below **10 %**. Under these conditions, enantiomeric purity stays within **±0.2 %** of the initial value for **24 months** at **25 °C/60 % RH** (ICH Q1A long‑term conditions). Accelerated testing at **40 °C/75 % RH** over **6 months** shows no detectable hydrolysis of the amide bond by FTIR carbonyl peak integration, confirming the robustness of the crystalline form. Chiral purity is verified on every production lot by high‑performance liquid chromatography using a Chiralpak IA‑3 column (**250 × 4.6 mm, 3 µm** particle size) with a mobile phase of hexane/ethanol/diethylamine (**90:10:0.1 v/v/v**) at a flow rate of **1.0 mL/min**. UV detection at **210 nm** yields a baseline resolution between the (S)-enantiomer at retention time **12.8 min** and the (R)-enantiomer at **14.6 min**. Integration of the (R)-peak shows an area percentage typically below **0.15 %**, corresponding to an enantiomeric excess ≥**99.7 %**. System suitability is assessed by injection of a racemic reference standard; the resolution factor must exceed **2.0** before sample sequences are acquired. The tartrate counterion is quantitated by ion‑pair chromatography on a C18 column with a phosphate‑buffered tetrabutylammonium mobile phase, calibrated against USP L‑tartrate reference material. The acceptable range for tartrate content is **33.0–34.5 % w/w**, bracketing the theoretical stoichiometric value of **33.7 %**. When coupling this intermediate to a substituted benzhydrol fragment in a Mitsunobu reaction, the tartrate must be converted in situ to the free amine. This is achieved by partitioning between dichloromethane and saturated sodium bicarbonate; the organic layer is dried over anhydrous magnesium sulfate and used immediately. Industrial batches processed in a 200 L reactor at **0.35 mol/L** concentration with a DIAD/triphenylphosphine couple (each **1.5 equiv**) have consistently delivered isolated yields of **72–78 %** after crystallization, versus **60–65 %** when the hydrochloride is used under the same conditions. The performance differential is attributed to the tartrate’s slower dissolution in the biphasic liberation system, which moderates the free‑amine concentration and reduces side‑product formation from premature nucleophilic attack on the activated phosphonium complex.

When a Non‑Hygroscopic Chiral Intermediate Enables Telescoped Reduction in THF

Borane‑dimethylsulfide reduction of the amide to the corresponding 3‑pyrrolidinylethylamine is sensitive to protic contaminants. The tartrate salt, once converted to the free base and dissolved in anhydrous tetrahydrofuran (KF <50 ppm), shows no detectable back‑reaction or borane consumption by residual water over a **6‑hour** addition window at **0 °C**. In contrast, the hydrochloride‑derived free base typically requires azeotropic drying with toluene to remove adventitious water, adding a **3‑4 hour** cycle to the campaign and exposing the sensitive amine to thermal racemization. Process‑scale infrared monitoring (ReactIR 15, Mettler Toledo) of the BH₃‑SMe₂ adduct band at **2340 cm⁻¹** confirms complete consumption of the reducing agent within **90 minutes** after final addition, with less than **2 %** variation in peak area between independent production runs. After an aqueous workup, the crude product is isolated as the fumarate salt without recrystallization, saving one solvent volume of isopropanol per kilogram, which directly reduces volatile organic carbon emission in line with EPA 40 CFR 63 guidelines. Catalytic hydrogenolysis of the diphenylmethyl protecting group on the pyrrolidine nitrogen provides another branch point for downstream diversification. The tartrate’s low affinity for palladium catalysts (no detectable phosphorus or sulfur impurities by ICP‑OES, limit <**1 ppm**) avoids the initial exotherm observed with certain tosylate salts that often contain trace thioesters. When the substrate is processed at **10 % w/v** in ethanol/water (**95:5**) with **5 % Pd/C** (Johnson Matthey type 87L, **0.02 molar equivalents Pd**) under **0.3 MPa** H₂, complete debenzylation is achieved in **4 hours** at **50 °C**. Enantiomeric enrichment is preserved with a final e.e. of **99.4 %** by chiral CE analysis, demonstrating the tartrate’s compatibility with transition‑metal‑catalyzed steps without erosion of stereochemical integrity. A recurring bottleneck in the kilo‑scale production of this compound is the filtration time following antisolvent crystallization. The tartrate salt forms needle‑shaped crystals of **20–50 µm** length when precipitated from methanol/MTBE mixtures; this morphology can bind solvent and slow filtration on a **30 cm** diameter Nutsche filter to over **2 hours**. A refinement of the crystallization protocol—controlled cooling from **60 °C** to **20 °C** at **0.2 °C/min** with overhead stirring at **150 rpm**—consistently produces a compact granular habit. Under these conditions, filtration time drops to **40–45 minutes**, and the solvent‑wet cake retains less than **3 %** excess MTBE by thermogravimetric headspace analysis. This process knowledge was derived from over **50 industrial batches**, representing approximately **1200 kg** of product, and is incorporated into the product’s manufacturer’s guidance notes. No premature nucleation was detected when seeding was introduced at **48 °C**, with a seed loading of **0.5 wt%** of the estimated theoretical yield. The use of this tartrate salt is contraindicated in aqueous alkaline media above **pH 9.0** for prolonged periods; while the amide bond is stable, the pyrrolidine ring’s basic nitrogen can promote slow racemization at the chiral center through a transient imine‑enamine tautomerization pathway. Published data for this specific degradation mechanism under manufacturing conditions is limited, but validation runs with solutions maintained at **pH 10.5** and **25 °C** showed an e.e. decrease of **0.8 % over 8 hours**, as measured by chiral SFC. Consequently, any liquid‑phase process requiring extended basic exposure should be monitored with in‑process chiral purity checks at **2‑hour** intervals. The solubility distinctions outlined in Table 2 drive process decisions. The moderate water solubility of the tartrate allows dissolution for salt metathesis in aqueous biphasic systems without forming the emulsions that plague hydrochloride extractions, reducing phase‑separation hold‑up times by an average of **22 %** across **35** recorded plant campaigns. In addition, near‑insolubility in ethyl acetate and acetone enables straightforward displacement washing of filter cakes to remove mother liquor impurities without product loss exceeding **0.3 %** of the batch mass, an important factor when scaling to multi‑hundred‑kilogram annual demand. The fumarate salt shows an even lower aqueous solubility, but its crystallization tendency from concentrated ethanolic solutions is poorly reproducible across production scales, frequently generating metastable polymorphs that complicate mechanical drying. Therefore, the L‑tartrate is preferred when a rationalized supply chain—from pilot‑scale demonstration to commercial‑scale delivery—requires a single salt form that performs consistently in solid‑liquid separation unit operations.

cGMP Intermediate Production and Counterion Integrity

Production campaigns conducted under ICH Q7 guidelines demonstrate that the tartrate counterion remains intact through the final recrystallization and drying steps. No free‑base loss due to dissociation is detected by charged aerosol detection (CAD) when the dried product is reconstituted in mobile phase and analyzed against a five‑point external standard curve prepared from the racemic tartrate reference, certified per ISO 17034. The correlation coefficient (r²) of the standard curve must exceed **0.9995** for batch release. The salt’s stoichiometry is further confirmed by ¹H NMR integration of the tartrate methine protons (δ **4.38 ppm**, s, **2H**) relative to the pyrrolidine C‑3 methine multiplet (δ **3.15–3.28 ppm**, **1H**): the observed ratio consistently falls between **1.98:1 and 2.02:1**. Any deviation outside this window triggers an investigation into potential residual free L‑tartrate from incomplete washing or partial salt disproportionation during drying, although no such event has been recorded in the last **50** batch records. At process scale, the compound is packed in food‑grade polyethylene liners inside UN‑approved fiber drums. Each drum carries a tamper‑evident seal and a batch‑specific certificate of analysis enumerating the test results against Table 1. A change‑control protocol, aligned with ICH Q10 pharmaceutical quality system elements, governs raw material sourcing; the supplier’s (R)-α,α‑diphenyl‑3‑pyrrolidineacetamide enantiomer—used as the starting material for chiral resolution—must be supplied with a certificate of origin demonstrating no source of bovine spongiform encephalopathy risk, as per EMA/410/01 Rev.3 guidance where applicable. Supply chain fidelity is preserved through annual on‑site audits of the key intermediate manufacturer, confirming compliance with ISO 9001:2015 and ISO 14001:2015.